Лучшие подкасты про The Lancet Diabetes (2024)

Professor Roy Taylor joins Lauren Southwell to talk about his Review discussing the causes of type 2 diabetes. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00157-8?dgcid=buzzsprout_icw_podcast_generic_landia Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https:/…

1
In conversation with... Ponnusamy Saravanan, Uma Ram, and Kosgei Wycliffe 33:42

Play Pause

6M ago33:42

33:42

Professor Ponnusamy Saravanan, Dr Uma Ram, and Dr Kosgei Wycliffe join Lauren Southwell to discuss STRiDE, a prospective cohort study in India and Kenya, and the multi-ethnic PRiDE cohort in the UK to assess early pregnancy HbA1c as a screening test for gestational diabetes.The Lancet

1
Ponnusamy Saravanan, Uma Ram, and Kosgei Wycliffe on early pregnancy HbA1c as a screening test for gestational diabetes 33:42

6M ago33:42

33:42

Professor Ponnusamy Saravanan, Dr Uma Ram, and Dr Kosgei Wycliffe join Lauren Southwell to discuss STRiDE, a prospective cohort study in India and Kenya, and the multi-ethnic PRiDE cohort in the UK to assess early pregnancy HbA1c as a screening test for gestational diabetes. Read the full article: https://www.thelancet.com/journals/landia/article/P…

1
Márta Korbonits on mechanisms of ageing 13:27

2y ago13:27

13:27

Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin. Read the full article: Mechanisms of ageing: growth hormone, dietary restriction, and metformin Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com…

1
In conversation with... Márta Korbonits 13:27

2y ago13:27

13:27

Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin.The Lancet

1
Mirjam Christ-Crain and Cihan Atila on the patient's perspective of central diabetes insipidus 8:17

2+ y ago8:17

8:17

Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective. Read the full article: Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey Conti…

1
In conversation with... Mirjam Christ-Crain and Cihan Atila 8:17

2+ y ago8:17

8:17

Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective.The Lancet

1
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma 9:42

2+ y ago9:42

9:42

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma. Read the full article: Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma Continue this conversation on social! Follow us today at... https://twi…

1
In conversation with... Niki Karavitaki 9:42

2+ y ago9:42

9:42

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.The Lancet

1
In conversation with... Rossella Nappi 17:28

2+ y ago17:28

17:28

Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women’s health.The Lancet

1
Rossella Nappi on menopause as a turning point for women's health 17:28

2+ y ago17:28

17:28

Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women’s health. Read the full Series: Menopause Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.c…

1
Louise Baur on the causes of child and adolescent obesity 11:26

2+ y ago11:26

11:26

Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches. Read the full article: Obesity in children and adolescents: epidemiology, causes, assessment, and management Continue this conversation on social! Follow us today at... https…

1
In conversation with... Louise Baur 11:26

2+ y ago11:26

11:26

Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches.The Lancet

1
Margherita Pizzato on the global epidemiological landscape of thyroid cancer 19:36

3y ago19:36

19:36

Margherita Pizzato talks with The Lancet Diabetes & Endocrinology about the global epidemiological landscape of thyroid cancer based on GLOBOCAN estimates in 2020. Read the full article: The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020 Continue this conversation on social! Follo…

1
In conversation with...Margherita Pizzato 19:36

3y ago19:36

19:36

Margherita Pizzato talks with The Lancet Diabetes & Endocrinology about the global epidemiological landscape of thyroid cancer based on GLOBOCAN estimates in 2020.The Lancet

1
In conversation with... Angela Titmuss 11:44

3y ago11:44

11:44

Angela Titmuss talks with The Lancet Diabetes & Endocrinology about youth-onset type 2 diabetes among First Nations young people in northern Australia.The Lancet

1
Angela Titmuss on T2D in First Nations young people in northern Australia 11:44

3y ago11:44

11:44

Angela Titmuss talks with The Lancet Diabetes & Endocrinology about youth-onset type 2 diabetes among First Nations young people in northern Australia. Read the full article: Youth-onset type 2 diabetes among First Nations young people in northern Australia Continue this conversation on social! Follow us today at... https://twitter.com/thelancet ht…

1
Sanjay Basu on affordable T2D medicine in LMICs 9:42

3y ago9:42

9:42

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext Continue this conversation on social! Follow us today at... https://tw…

1
In conversation with... Sanjay Basu 9:42

3y ago9:42

9:42

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.The Lancet

1
Philip Home on the centenary of insulin 13:00

3+ y ago13:00

13:00

Philip Home talks with The Lancet Diabetes & Endocrinology about the insulin centenary and how insulin therapy might develop in the future. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00182-0/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://insta…

1
In conversation with... Philip Home 13:00

3+ y ago13:00

13:00

Philip Home talks with The Lancet Diabetes & Endocrinology about the insulin centenary and how insulin therapy might develop in the future.The Lancet

1
Victoria Salem on improving female inclusion in conferences 11:52

3+ y ago11:52

11:52

Victoria Salem talks with The Lancet Diabetes & Endocrinology about how to improve female inclusion and participation in scientific medical conferences. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00177-7/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet …

1
In conversation with... Victoria Salem 11:52

3+ y ago11:52

11:52

Victoria Salem talks with The Lancet Diabetes & Endocrinology about how to improve female inclusion and participation in scientific medical conferences.The Lancet

1
In conversation with... Hertzel Gerstein 24:00

3+ y ago24:00

24:00

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.The Lancet

1
Hertzel Gerstein on dulaglutide, erectile dysfunction, and T2D 24:00

3+ y ago24:00

24:00

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00115-7/fulltext Continue this conversation on social! Follow us today at..…

1
In conversation with... Rishi Caleyachetty 5:40

3+ y ago5:40

5:40

Rishi Caleyachetty talks with The Lancet Diabetes & Endocrinology about the need to revise ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk.The Lancet

1
Rishi Caleyachetty on ethnicity-specific BMI 5:40

3+ y ago5:40

5:40

Rishi Caleyachetty talks with The Lancet Diabetes & Endocrinology about the need to revise ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00088-7/fulltext Continue this conversation on social! Follow us today at... https://twitter.co…

1
In Conversation With... Thomas Robinson 17:41

3+ y ago17:41

17:41

Thomas Robinson talks with The Lancet Diabetes & Endocrinology about the Stanford GOALS randomised controlled trial in Latinx children with overweight or obesity.The Lancet

1
Thomas Robinson on obesity in Latinx children 17:41

3+ y ago17:41

17:41

Thomas Robinson talks with The Lancet Diabetes & Endocrinology about the Stanford GOALS randomised controlled trial in Latinx children with overweight or obesity. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00084-X/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/…

1
In Conversation With... Adrian Martineau 10:26

3+ y ago10:26

10:26

Adrian Martineau talks with The Lancet Diabetes & Endocrinology about how vitamin D supplementation can reduce the risk of acute respiratory infections.The Lancet

1
Adrian Martineau on Vitamin D and respiratory infections 10:26

3+ y ago10:26

10:26

Adrian Martineau talks with The Lancet Diabetes & Endocrinology about how vitamin D supplementation can reduce the risk of acute respiratory infections. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00051-6/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet …

1
Calorie restriction and cardiometabolic risk 5:27

5+ y ago5:27

5:27

William Kraus talks with The Lancet Diabetes & Endocrinology about how calorie restriction can reduce cardiometabolic risk even in young, healthy, non-obese adults. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linke…

1
Calorie restriction and cardiometabolic risk 6:07

5+ y ago6:07

6:07

William Kraus talks with The Lancet Diabetes & Endocrinology about how calorie restriction can reduce cardiometabolic risk even in young, healthy, non-obese adults.The Lancet

1
Albuminuria and end-stage kidney disease 9:49

6y ago9:49

9:49

Hiddo Lambers Heerspink talks with The Lancet Diabetes & Endocrinology about his work on changes in albuminuria and subsequent effect on kidney disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/comp…

1
Albuminuria and end-stage kidney disease 10:13

6y ago10:13

10:13

Hiddo Lambers Heerspink talks with The Lancet Diabetes & Endocrinology about his work on changes in albuminuria and subsequent effect on kidney disease.The Lancet

1
Type 1 diabetes and immune-based therapies 17:28

6y ago17:28

17:28

Mark Atkinson and Bart Roep join The Lancet Diabetes & Endocrinology to discuss a new Series on immune-based therapies for type 1 diabetes. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lance…

1
Type 1 diabetes and immune-based therapies 18:00

6y ago18:00

18:00

Mark Atkinson and Bart Roep join The Lancet Diabetes & Endocrinology to discuss a new Series on immune-based therapies for type 1 diabetes.The Lancet

1
Ageing and endocrinology 25:07

6+ y ago25:07

25:07

Series authors Annewieke van den Beld, Bu Yeap, Robin Peeters, and Zaki Hassan-Smith discuss how the endocrine system changes with age and the implications for healthy ageing. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal ht…

1
Ageing and endocrinology 25:32

6+ y ago25:32

25:32

Series authors Annewieke van den Beld, Bu Yeap, Robin Peeters, and Zaki Hassan-Smith discuss how the endocrine system changes with age and the implications for healthy ageing.The Lancet

1
Prediabetes in the USA 13:06

7y ago13:06

13:06

Mohammed Ali talks to The Lancet Diabetes & Endocrinology about the cardiovascular and renal burdens of prediabetes in the USA. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://yo…

1
Prediabetes in the USA 14:10

7y ago14:10

14:10

Mohammed Ali talks to The Lancet Diabetes & Endocrinology about the cardiovascular and renal burdens of prediabetes in the USA.The Lancet

1
Frequency of T1D: The Lancet Diabetes & Endocrinology: November 30, 2017 5:27

7y ago5:27

5:27

Richard Oram discusses a study which uses UK Biobank data to look at the frequency of type 1 diabetes across the first six decades of life. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lance…

1
Frequency of T1D: The Lancet Diabetes & Endocrinology: November 30, 2017 5:40

7y ago5:40

5:40

Richard Oram discusses a study which uses UK Biobank data to look at the frequency of type 1 diabetes across the first six decades of life.The Lancet

1
Iodine and child development: The Lancet Diabetes & Endocrinology: October 10, 2017 7:25

7y ago7:25

7:25

Michael Zimmerman talks about the effect of iodine supplementation in pregnant women on child development.The Lancet

1
Iodine and child development: The Lancet Diabetes & Endocrinology: October 10, 2017 6:33

7y ago6:33

6:33

Michael Zimmerman talks about the effect of iodine supplementation in pregnant women on child development. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…

1
Diabetes in sub-Saharan Africa: The Lancet Diabetes & Endocrinology: July 5, 2017 6:54

7+ y ago6:54

6:54

Moffat Nyirenda talks about the challenges facing diabetes in sub-Saharan Africa, as highlighted in a new Commission.The Lancet

1
Diabetes in sub-Saharan Africa: The Lancet Diabetes & Endocrinology: July 5, 2017 6:33

7+ y ago6:33

6:33

Moffat Nyirenda talks about the challenges facing diabetes in sub-Saharan Africa, as highlighted in a new Commission. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/…

1
Outcomes after adrenalectomy: The Lancet Diabetes & Endocrinology: May 30, 2017 7:38

7+ y ago7:38

7:38

Martin Reincke discusses outcomes after adrenalectomy for unilateral primary aldosteronism. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…

1
Outcomes after adrenalectomy: The Lancet Diabetes & Endocrinology: May 30, 2017 8:08

7+ y ago8:08

8:08

Martin Reincke discusses outcomes after adrenalectomy for unilateral primary aldosteronism.The Lancet

Подкасты, которые стоит послушать

Подкасты на тему The Lancet Diabetes

Подкасты, которые стоит послушать

Краткое руководство